Effect of CLDN1 mAb on primary patient derived liver organoids

ABSTRACT: Organoids were established from non-tumorous cirrhotic liver tissue and treated with CLDN1 mAb or Control mAb for 4 days. Organoids were harvested and mRNA was extracted. RNAsequencing was performed for comparative gene expression profiling.

ORGANISM(S): Homo sapiens

PROVIDER: GSE206581 | GEO | 2024/03/12

REPOSITORIES: GEO